NDC 55513-137

Otezla

Apremilast

Otezla is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Amgen Inc. The primary component is Apremilast.

Product ID55513-137_10ac0969-71a1-4429-924e-f638d552f7b9
NDC55513-137
Product TypeHuman Prescription Drug
Proprietary NameOtezla
Generic NameApremilast
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2020-02-26
Marketing CategoryNDA / NDA
Application NumberNDA205437
Labeler NameAmgen Inc
Substance NameAPREMILAST
Active Ingredient Strength30 mg/1
Pharm ClassesPhosphodiesterase 4 Inhibitor [EPC],Phosphodiesterase 4 Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 55513-137-28

1 BLISTER PACK in 1 CARTON (55513-137-28) > 28 TABLET, FILM COATED in 1 BLISTER PACK
Marketing Start Date2020-02-26
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 55513-137-28 [55513013728]

Otezla TABLET, FILM COATED
Marketing CategoryNDA
Application NumberNDA205437
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2020-02-26

NDC 55513-137-60 [55513013760]

Otezla TABLET, FILM COATED
Marketing CategoryNDA
Application NumberNDA205437
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2020-02-26

Drug Details

Active Ingredients

IngredientStrength
APREMILAST30 mg/1

OpenFDA Data

SPL SET ID:f6b1f516-4972-4d82-bced-113e47b41cc5
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1605454
  • 1605455
  • 1492747
  • 1492746
  • 1492732
  • 1492744
  • 1492742
  • 1492740
  • 1492738
  • 1492748
  • UPC Code
  • 0355513137607
  • Pharmacological Class

    • Phosphodiesterase 4 Inhibitor [EPC]
    • Phosphodiesterase 4 Inhibitors [MoA]

    NDC Crossover Matching brand name "Otezla" or generic name "Apremilast"

    NDCBrand NameGeneric Name
    55513-137Otezlaapremilast
    55513-369Otezlaapremilast
    55513-485Otezlaapremilast
    59572-630OTEZLAapremilast
    59572-631OTEZLAapremilast
    59572-632OTEZLAapremilast
    70518-3155Otezlaapremilast
    60219-1410APREMILASTAPREMILAST
    60219-1744APREMILASTAPREMILAST

    Trademark Results [Otezla]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    OTEZLA
    OTEZLA
    86109590 4598910 Live/Registered
    Celgene Corporation
    2013-11-04
    OTEZLA
    OTEZLA
    86093816 4598865 Live/Registered
    Celgene Corporation
    2013-10-17
    OTEZLA
    OTEZLA
    85705380 4331247 Live/Registered
    Celgene Corporation
    2012-08-16

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.